dapsone has been researched along with Pemphigus in 112 studies
Pemphigus: Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the efficacy of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris (PV)." | 9.13 | Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris. ( Albrecht, J; Chen, D; Fivenson, D; Jacobus, D; Pandya, AG; Rico, MJ; Werth, VP, 2008) |
| " Patients We observed 9 consecutive adult patients with pemphigus vulgaris being treated with immunosuppressants who were unable to taper prednisone use without abrupt worsening of their disease." | 7.73 | Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris. ( Albrecht, J; Heaphy, MR; Werth, VP, 2005) |
| "We describe a case of pemphigus foliaceus complicated by dapsone-induced motor peripheral neuropathy." | 7.69 | Dapsone-induced motor peripheral neuropathy in pemphigus foliaceus. ( Coleman, MD; Lewis-Jones, MS; Rhodes, LE, 1995) |
| "Auranofin (AF), an oral gold salt, was given for 9-18 months to 3 patients with pemphigus vulgaris." | 7.67 | Oral gold therapy (Auranofin) in pemphigus vulgaris. ( Salomon, D; Saurat, JH, 1986) |
| "Human epidermal cells were cultured with pemphigus antibody in the presence of hydrocortisone, methylprednisolone sodium succinate, dapsone and gold." | 7.67 | The effect of corticosteroids, dapsone and gold upon plasminogen activator synthesis and secretion by human epidermal cells cultured with pemphigus antibody. ( Hashimoto, K; Lazarus, GS; Singer, K, 1984) |
| "Nine cases of superficial pemphigus that were treated by dapsone as the initial mode of therapy are reported." | 7.67 | Dapsone as initial treatment in superficial pemphigus. Report of nine cases. ( Basset, N; Guilhou, JJ; Guillot, B; Meynadier, J; Michel, B, 1987) |
| "This is a report on two cases with pemphigus vulgaris effectively controlled by dapsone." | 7.66 | Dapsone in the treatment of pemphigus vulgaris. ( Friedman-Birnbaum, R; Haim, S, 1978) |
| "Three uncomplicated cases of pemphigus were clinically controlled by dapsone." | 7.65 | Pemphigus controlled by dapsone. ( Piamphongsant, T, 1976) |
| "Dapsone is a chemotherapeutic agent primarily used in treating leprosy, Pneumocystis jiroveci (previously carinii) pneumonia, and malaria." | 6.45 | Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data. ( Ahmed, AR; Gürcan, HM, 2009) |
| "Dapsone is a chemotherapeutic agent with anti-inflammatory properties that is used as a steroid-sparing agent in PV." | 5.43 | Efficacy of Dapsone in the Treatment of Pemphigus Vulgaris: A Single-Center Case Study. ( Barzilai, A; Baum, S; Debby, A; Gilboa, S; Trau, H, 2016) |
| "IgA pemphigus is a particular entity among autoimmune blistering intraepidermal diseases." | 5.39 | [Efficacy of acitretin in IgA pemphigus]. ( Bellissen, A; Gosset, P; Lasek, A; Lebas, D; Modiano, P; Wantz, M, 2013) |
| "IgA pemphigus of the subcorneal pustular dermatosis type is a rare autoimmune blistering disease in the pemphigus spectrum." | 5.38 | [IgA pemphigus of the subcorneal pustular dermatosis type. Successful therapy with a combination of dapsone and acitretin]. ( Groiß, E; Haensch, N; Hashimoto, T; Monshi, B; Rappersberger, K; Richter, L, 2012) |
| "Tacrolimus was well tolerated, and clinical improvement allowed tapering of corticosteroids." | 5.36 | Recalcitrant pemphigus vulgaris responding to systemic tacrolimus. ( Bruckner-Tuderman, L; Büsing, V; Hofmann, SC; Kern, JS, 2010) |
| "Dapsone was easily withdrawn at the onset of remission." | 5.27 | Use of cyclophosphamide in azathioprine failures in pemphigus. ( Ahmed, AR; Hombal, S, 1987) |
| "To determine the efficacy of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris (PV)." | 5.13 | Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris. ( Albrecht, J; Chen, D; Fivenson, D; Jacobus, D; Pandya, AG; Rico, MJ; Werth, VP, 2008) |
| "A suggested protocol to treat pemphigus is presented." | 3.75 | Adjuvant therapy of pemphigus. ( Bystryn, JC, 1984) |
| " Patients We observed 9 consecutive adult patients with pemphigus vulgaris being treated with immunosuppressants who were unable to taper prednisone use without abrupt worsening of their disease." | 3.73 | Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris. ( Albrecht, J; Heaphy, MR; Werth, VP, 2005) |
| "We describe a case of pemphigus foliaceus complicated by dapsone-induced motor peripheral neuropathy." | 3.69 | Dapsone-induced motor peripheral neuropathy in pemphigus foliaceus. ( Coleman, MD; Lewis-Jones, MS; Rhodes, LE, 1995) |
| "A male patient who was being treated with oral prednisone for erosive mucocutaneous pemphigus lesions developed fever, jaundice, a rash, and anemia within 2 wk of starting dapsone therapy." | 3.69 | Sulfone syndrome in a patient receiving steroids for pemphigus. ( Barnard, GF; Dagher, RK; Scharf, MJ, 1994) |
| "Nine cases of superficial pemphigus that were treated by dapsone as the initial mode of therapy are reported." | 3.67 | Dapsone as initial treatment in superficial pemphigus. Report of nine cases. ( Basset, N; Guilhou, JJ; Guillot, B; Meynadier, J; Michel, B, 1987) |
| "Human epidermal cells were cultured with pemphigus antibody in the presence of hydrocortisone, methylprednisolone sodium succinate, dapsone and gold." | 3.67 | The effect of corticosteroids, dapsone and gold upon plasminogen activator synthesis and secretion by human epidermal cells cultured with pemphigus antibody. ( Hashimoto, K; Lazarus, GS; Singer, K, 1984) |
| "Auranofin (AF), an oral gold salt, was given for 9-18 months to 3 patients with pemphigus vulgaris." | 3.67 | Oral gold therapy (Auranofin) in pemphigus vulgaris. ( Salomon, D; Saurat, JH, 1986) |
| "This is a report on two cases with pemphigus vulgaris effectively controlled by dapsone." | 3.66 | Dapsone in the treatment of pemphigus vulgaris. ( Friedman-Birnbaum, R; Haim, S, 1978) |
| "Three uncomplicated cases of pemphigus were clinically controlled by dapsone." | 3.65 | Pemphigus controlled by dapsone. ( Piamphongsant, T, 1976) |
| "The data on the effect of treatments used for pemphigus on COVID-19 are limited." | 2.66 | Pemphigus and COVID-19: Critical overview of management with a focus on treatment choice. ( Atasoy, M; Demirbaş, A; Elmas, ÖF; Lotti, T; Türsen, Ü, 2020) |
| "Pemphigus is a group of autoimmune intraepidermal bullous diseases; being pemphigus foliaceus (PF) and pemphigus vulgaris (PV) the most common subtypes." | 2.53 | Pemphigus foliaceus with circinated plaques and neutrophil pustules. ( Avalos-Diaz, E; Dominguez-Cherit, J; Esquivel-Pedraza, L; Méndez-Flores, S; Saeb-Lima, M, 2016) |
| "Treatment modalities in pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are many and varied, although level 1 evidence supporting their use is limited." | 2.47 | Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus. ( Frew, JW; Martin, LK; Murrell, DF, 2011) |
| "Pemphigus vulgaris is an infrequent but life-threatening autoimmune blistering disease that is rare in the pediatric age." | 2.46 | Rituximab in childhood pemphigus vulgaris: a long-term follow-up case and review of the literature. ( Fuertes, I; Guilabert, A; Iranzo, P; Mascaró, JM, 2010) |
| "Dapsone is a chemotherapeutic agent primarily used in treating leprosy, Pneumocystis jiroveci (previously carinii) pneumonia, and malaria." | 2.45 | Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data. ( Ahmed, AR; Gürcan, HM, 2009) |
| "Pemphigus vulgaris is a rare, chronic, autoimmune mucocutaneous blistering disease." | 2.43 | Treatment of pemphigus vulgaris: current and emerging options. ( Ahmed, RA; Sami, N; Yeh, SW, 2005) |
| "In 1964, Sweet described an acute febrile neutrophilic dermatosis." | 2.43 | From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research. ( Vignon-Pennamen, MD; Wallach, D, 2006) |
| "Pemphigus is an autoimmune skin disease that can present in a variety of forms and can be a challenging disease to manage and treat." | 2.42 | Pemphigus: current therapy. ( Rosenkrantz, WS, 2004) |
| "A review of canine pemphigus vulgaris, pemphigus vegetans, pemphigus foliaceus, pemphigus erythematosus, and bullous pemphigoid shows them to share many clinicopathologic similarities with their human counterparts." | 2.36 | Pemphigus and pemphigoid in dog and man: comparative aspects. ( Lewis, RM; Scott, DW, 1981) |
| "Azathioprine 50 mg orally was then used in place of dapsone due to rapid disease progression with extensive skin involvement." | 1.91 | Rescue treatment with intravenous immunoglobulin and amniotic membrane dressing in refractory paediatric pemphigus vulgaris with sepsis. ( Akham, R; Bhatia, R; Hazarika, N; Paonam, R, 2023) |
| "Dapsone alone was inefficient." | 1.48 | Pemphigus herpetiformis in South Tunisia: a clinical expression of pemphigus foliaceus? ( Abida, O; Bahloul, E; Bouzid, A; Charfi, S; Feki, S; Hachicha, H; Jerbi, A; Masmoudi, A; Masmoudi, H; Sellami Boudawara, T; Sellami, K; Turki, H, 2018) |
| "Dapsone is a chemotherapeutic agent with anti-inflammatory properties that is used as a steroid-sparing agent in PV." | 1.43 | Efficacy of Dapsone in the Treatment of Pemphigus Vulgaris: A Single-Center Case Study. ( Barzilai, A; Baum, S; Debby, A; Gilboa, S; Trau, H, 2016) |
| "IgA pemphigus is a particular entity among autoimmune blistering intraepidermal diseases." | 1.39 | [Efficacy of acitretin in IgA pemphigus]. ( Bellissen, A; Gosset, P; Lasek, A; Lebas, D; Modiano, P; Wantz, M, 2013) |
| "IgA pemphigus of the subcorneal pustular dermatosis type is a rare autoimmune blistering disease in the pemphigus spectrum." | 1.38 | [IgA pemphigus of the subcorneal pustular dermatosis type. Successful therapy with a combination of dapsone and acitretin]. ( Groiß, E; Haensch, N; Hashimoto, T; Monshi, B; Rappersberger, K; Richter, L, 2012) |
| "Pemphigus is the most common and severe autoimmune bullous disease in Korea." | 1.37 | Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients. ( Kim, HC; Kim, MR; Kim, SC, 2011) |
| "We report three adolescents with pemphigus vulgaris whose disease started at the age of 13, 15 and 14 years, respectively." | 1.37 | Pemphigus vulgaris in three adolescents: the course of the disease. ( Djakovic, Z; Medenica, L; Nikolic, M; Popadic, S; Skiljevic, D, 2011) |
| "Tacrolimus was well tolerated, and clinical improvement allowed tapering of corticosteroids." | 1.36 | Recalcitrant pemphigus vulgaris responding to systemic tacrolimus. ( Bruckner-Tuderman, L; Büsing, V; Hofmann, SC; Kern, JS, 2010) |
| "Three types of pemphigus have been described, including pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus." | 1.36 | [Pemphigus]. ( Joly, P; Lapeyre-Liénard, H, 2010) |
| "We report a case of subcorneal pustular dermatosis (SPD) in a patient with rheumatoid arthritis (RA) and diffuse scleroderma." | 1.35 | Subcorneal pustular dermatosis in a patient with rheumatoid arthritis and diffuse scleroderma. ( Brantley, EI; Sheth, P, 2009) |
| "Dapsone was the mainstay of treatment for the patients with PF." | 1.35 | A clinical study of patients with pemphigus vulgaris and pemphigus foliaceous: an 11-year retrospective study (1996-2006). ( Hashimoto, T; Ishii, N; Karashima, T; Kusuhara, M; Maeyama, Y; Nakama, T; Yasumoto, S, 2008) |
| "Acantholysis was observed in the spinous layer of the lesional epidermis and direct immunofluorescence revealed cell surface deposition of immunoglobulin IgG and C3." | 1.34 | IgG/IgA pemphigus with dyskeratotic acantholysis and intraepidermal neutrophilic microabscesses. ( Hashimoto, T; Ikeda, M; Kodama, H; Nakajima, H; Nakajima, K; Yokogawa, M, 2007) |
| "Pemphigus is a disease demonstrating an uneven geographic distribution." | 1.33 | Epidemiology of pemphigus in south-western Iran: a 10-year retrospective study (1991-2000). ( Namazi, MR; Rahman-Shenas, MR; Salmanpour, R; Shahkar, H, 2006) |
| "Pemphigus vulgaris is the commonest clinical type." | 1.33 | Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases. ( Garg, G; Mahajan, VK; Sharma, NL; Sharma, RC, 2005) |
| "IgA pemphigus is a rare pustular autoimmune disease with exclusive IgA anti-keratinocyte cell surface antibody reactivity." | 1.33 | IgA pemphigus--occurrence of anti-desmocollin 1 and anti-desmoglein 1 antibody reactivity in an individual patient. ( Födinger, D; Karlhofer, FM; Kopp, T; Pieczkowski, F; Schneeberger, A; Sitaru, C; Stingl, G; Zillikens, D, 2006) |
| "The drug of choice for treating IgA pemphigus is diaminodiphenylsulfone." | 1.33 | [Successful treatment of subcorneal pustular type of IgA pemphigus]. ( Hashimoto, T; Kapp, A; Petering, H; Raap, U; Völker, B; Werfel, T; Zillikens, D, 2005) |
| "We describe an unusual presentation of pemphigus vulgaris, an autoimmune intraepidermal blistering skin disease associated with autoantibodies to the desmosome glycoprotein, desmoglein 3." | 1.31 | An unusual case of pemphigus vulgaris presenting as bilateral foot ulcers. ( Tan, HH; Tay, YK, 2000) |
| "In comparison to pediatric cases of pemphigus vulgaris, sporadic pemphigus foliaceus in children tends to follow a generally benign course of relatively short duration." | 1.31 | Nonendemic pemphigus foliaceus in children. ( Hebert, AA; Jordon, RE; Metry, DW, 2002) |
| "IgA pemphigus is a rare neutrophilic acantholytic skin disorder with only approximately 70 cases reported in the indexed literature to date." | 1.31 | IgA pemphigus: the first two Scandinavian cases. ( Bygum, A; Clemmensen, O; Gniadecki, R; Svejgaard, E; Ullman, S, 2002) |
| "Pemphigus foliaceus is a skin disease in which antibodies against the cell surface of keratinocytes destroy the adhesion between epidermal cells, thereby producing blisters." | 1.30 | Pemphigus foliaceus. ( Cambazard, F; Clavel, C; Galambrun, C; Stéphan, JL; Versini, P, 1997) |
| "Although pemphigus is a well-characterized entity, detailed epidemiologic studies from the Arabian Peninsula are not available." | 1.30 | Pemphigus in Kuwait. ( Al-Baghli, NM; Alsaleh, QA; Dvorak, R; Nanda, A, 1999) |
| "Dermatitis herpetiformis, pemphigus vulgaris, and bullous pemphigoid are uncommon, but not rare, blistering diseases." | 1.28 | Three blistering diseases. Why proper management is critical. ( Wooldridge, WE, 1990) |
| "Seven cases of juvenile pemphigus vulgaris and one case of juvenile pemphigus foliaceus are presented." | 1.27 | Juvenile pemphigus. ( Ahmed, AR; Salm, M, 1983) |
| "Dapsone was easily withdrawn at the onset of remission." | 1.27 | Use of cyclophosphamide in azathioprine failures in pemphigus. ( Ahmed, AR; Hombal, S, 1987) |
| "Subcorneal dermatosis is a chronic relapsing pustular eruption which has been recognised for 20 years." | 1.26 | [Subcorneal pustular dermatosis]. ( Sneddon, IB, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 33 (29.46) | 18.7374 |
| 1990's | 15 (13.39) | 18.2507 |
| 2000's | 30 (26.79) | 29.6817 |
| 2010's | 31 (27.68) | 24.3611 |
| 2020's | 3 (2.68) | 2.80 |
| Authors | Studies |
|---|---|
| Akham, R | 1 |
| Bhatia, R | 1 |
| Paonam, R | 1 |
| Hazarika, N | 1 |
| Bahloul, E | 2 |
| Hammami, F | 1 |
| Jerbi, A | 2 |
| Abida, O | 2 |
| Sellami, K | 2 |
| Hachicha, H | 2 |
| Amouri, M | 1 |
| Boudaya, S | 1 |
| Mseddi, M | 1 |
| Masmoudi, H | 2 |
| Masmoudi, A | 2 |
| Turki, H | 2 |
| Elmas, ÖF | 1 |
| Demirbaş, A | 1 |
| Türsen, Ü | 1 |
| Atasoy, M | 1 |
| Lotti, T | 1 |
| Peterman, CM | 1 |
| Vadeboncoeur, S | 1 |
| Schmidt, BA | 1 |
| Gellis, SE | 1 |
| Reichel, A | 1 |
| Benoit, S | 1 |
| Giner, T | 1 |
| Schmidt, E | 1 |
| Goebeler, M | 1 |
| Stoevesandt, J | 1 |
| Stojković-Filipović, J | 1 |
| Lekić, B | 1 |
| Milčić, D | 1 |
| Milinković, MV | 1 |
| Van-de-Velde, V | 2 |
| Matthews, AG | 2 |
| Biswas, A | 2 |
| Austin, E | 1 |
| Millsop, JW | 1 |
| Ely, H | 1 |
| Jagdeo, J | 1 |
| Schulman, JM | 1 |
| Feki, S | 1 |
| Charfi, S | 1 |
| Bouzid, A | 1 |
| Sellami Boudawara, T | 1 |
| Zaouak, A | 1 |
| Jouini, R | 1 |
| Koubaa, W | 1 |
| Hammami, H | 1 |
| Fenniche, S | 1 |
| Rodriguez-Vivian, C | 1 |
| González-Benavides, N | 1 |
| Herz-Ruelas, ME | 1 |
| Ocampo-Candiani, J | 1 |
| Mizukami, Y | 1 |
| Imanishi, H | 1 |
| Tateishi, C | 1 |
| Kaneshiro, S | 1 |
| Sowa-Osako, J | 1 |
| Ohsawa, M | 1 |
| Tsuruta, D | 1 |
| Apalla, Z | 1 |
| Sotiriou, E | 1 |
| Lazaridou, E | 1 |
| Manousari, A | 1 |
| Trigoni, A | 1 |
| Papagarifallou, I | 1 |
| Ioannides, D | 1 |
| Matsukura, S | 1 |
| Takahashi, K | 1 |
| Hirokado, M | 1 |
| Ikezawa, Y | 1 |
| Nakamura, K | 1 |
| Fukuda, S | 1 |
| Hashimoto, T | 10 |
| Ikezawa, Z | 1 |
| Aihara, M | 1 |
| Kambara, T | 1 |
| Bellissen, A | 1 |
| Lebas, D | 1 |
| Wantz, M | 1 |
| Gosset, P | 1 |
| Lasek, A | 1 |
| Modiano, P | 1 |
| Moreno, AC | 1 |
| Santi, CG | 1 |
| Gabbi, TV | 1 |
| Aoki, V | 1 |
| Maruta, CW | 1 |
| Ansai, O | 1 |
| Shimomura, Y | 1 |
| Fujimoto, A | 1 |
| Sakai, A | 1 |
| Tsuchida, Y | 1 |
| Hayashi, R | 1 |
| Shigehara, Y | 1 |
| Hama, N | 1 |
| Abe, R | 1 |
| Galvañ-Pérez Del Pulgar, JI | 1 |
| Tercedor-Sánchez, J | 1 |
| Jiménez-Gallo, D | 1 |
| Linares-Barrios, M | 1 |
| Watts, PJ | 1 |
| Khachemoune, A | 1 |
| Méndez-Flores, S | 1 |
| Avalos-Diaz, E | 1 |
| Dominguez-Cherit, J | 1 |
| Saeb-Lima, M | 1 |
| Esquivel-Pedraza, L | 1 |
| Baum, S | 1 |
| Debby, A | 1 |
| Gilboa, S | 1 |
| Trau, H | 1 |
| Barzilai, A | 1 |
| Lehman, JS | 1 |
| Mueller, KK | 1 |
| Schraith, DF | 1 |
| Ishii, N | 1 |
| Maeyama, Y | 1 |
| Karashima, T | 1 |
| Nakama, T | 1 |
| Kusuhara, M | 1 |
| Yasumoto, S | 1 |
| Brantley, EI | 1 |
| Sheth, P | 1 |
| Gürcan, HM | 1 |
| Ahmed, AR | 4 |
| Fuertes, I | 1 |
| Guilabert, A | 1 |
| Mascaró, JM | 1 |
| Iranzo, P | 1 |
| Nakashima, H | 1 |
| Fujimoto, M | 1 |
| Watanabe, R | 1 |
| Ishiura, N | 1 |
| Yamamoto, AI | 1 |
| Tamaki, K | 1 |
| Büsing, V | 1 |
| Kern, JS | 1 |
| Bruckner-Tuderman, L | 1 |
| Hofmann, SC | 1 |
| Lapeyre-Liénard, H | 1 |
| Joly, P | 1 |
| Moutran, R | 1 |
| Maatouk, I | 1 |
| Stephan, F | 1 |
| Halaby, E | 1 |
| Abadjian, G | 1 |
| Tomb, R | 1 |
| Montgomery, JR | 1 |
| Chan, LS | 1 |
| Popadic, S | 1 |
| Medenica, L | 1 |
| Skiljevic, D | 1 |
| Djakovic, Z | 1 |
| Nikolic, M | 1 |
| Frew, JW | 1 |
| Martin, LK | 2 |
| Murrell, DF | 2 |
| Kim, MR | 1 |
| Kim, HC | 1 |
| Kim, SC | 2 |
| Monshi, B | 1 |
| Richter, L | 1 |
| Groiß, E | 1 |
| Haensch, N | 1 |
| Rappersberger, K | 1 |
| Sung, JY | 1 |
| Lee, SE | 1 |
| Ingen-Housz-Oro, S | 1 |
| Alexandre, M | 1 |
| Le Roux-Villet, C | 1 |
| Picard-Dahan, C | 1 |
| Tancrède-Bohin, E | 1 |
| Wallet-Faber, N | 1 |
| Mahé, E | 1 |
| Begon, E | 1 |
| Francès, C | 1 |
| Sigal, M | 1 |
| Grootenboer-Mignot, S | 1 |
| Aucouturier, F | 1 |
| André, C | 1 |
| Wolkenstein, P | 1 |
| Chosidow, O | 1 |
| Prost-Squarcioni, C | 1 |
| Gniadecki, R | 1 |
| Bygum, A | 1 |
| Clemmensen, O | 1 |
| Svejgaard, E | 1 |
| Ullman, S | 1 |
| Hartz, RS | 1 |
| Daroca, PJ | 1 |
| Stoopler, ET | 1 |
| Sollecito, TP | 1 |
| DeRossi, SS | 1 |
| Rosenkrantz, WS | 1 |
| Raap, U | 1 |
| Völker, B | 1 |
| Petering, H | 1 |
| Zillikens, D | 3 |
| Kapp, A | 1 |
| Werfel, T | 1 |
| Heaphy, MR | 1 |
| Albrecht, J | 2 |
| Werth, VP | 2 |
| Mahajan, VK | 1 |
| Sharma, NL | 1 |
| Sharma, RC | 1 |
| Garg, G | 1 |
| Yeh, SW | 1 |
| Sami, N | 1 |
| Ahmed, RA | 1 |
| Takahashi, H | 1 |
| Tanaka, M | 1 |
| Tanikawa, A | 1 |
| Toyohara, A | 1 |
| Ogo, Y | 1 |
| Morimoto, A | 1 |
| Harato, R | 1 |
| Kobayashi, M | 1 |
| Amagai, M | 1 |
| Salmanpour, R | 1 |
| Shahkar, H | 1 |
| Namazi, MR | 1 |
| Rahman-Shenas, MR | 1 |
| Wong, YW | 1 |
| Ratnavel, RC | 1 |
| Grabczynska, SA | 1 |
| Cianchini, G | 1 |
| Lembo, L | 1 |
| Colonna, L | 1 |
| Puddu, P | 1 |
| Wallach, D | 1 |
| Vignon-Pennamen, MD | 1 |
| Kopp, T | 1 |
| Sitaru, C | 1 |
| Pieczkowski, F | 1 |
| Schneeberger, A | 1 |
| Födinger, D | 1 |
| Stingl, G | 1 |
| Karlhofer, FM | 1 |
| Olszewska, M | 1 |
| Gerlicz, Z | 1 |
| Blaszczyk, M | 1 |
| Zhou, JG | 1 |
| Cai, SQ | 1 |
| Zheng, M | 1 |
| Erdag, G | 1 |
| Qureshi, HS | 1 |
| Greer, KE | 1 |
| Patterson, JW | 1 |
| Nakajima, K | 1 |
| Nakajima, H | 1 |
| Yokogawa, M | 1 |
| Ikeda, M | 1 |
| Kodama, H | 1 |
| Fivenson, D | 1 |
| Pandya, AG | 1 |
| Chen, D | 1 |
| Rico, MJ | 1 |
| Jacobus, D | 1 |
| Weger, W | 1 |
| Aberer, E | 1 |
| Salm, M | 1 |
| Bystryn, JC | 2 |
| Hashimoto, K | 1 |
| Singer, K | 1 |
| Lazarus, GS | 1 |
| Weidner, F | 1 |
| Kötteritz, H | 1 |
| Jeffes, EW | 1 |
| Kaplan, RP | 1 |
| Scott, DW | 1 |
| Lewis, RM | 1 |
| Bauer, R | 1 |
| Orfanos, CE | 1 |
| Jablonska, S | 1 |
| Chorzelski, T | 1 |
| Parodi, A | 2 |
| Nunzi, E | 1 |
| Rebora, A | 2 |
| Pearson, RW | 1 |
| O'Donoghue, M | 1 |
| Kaplan, SJ | 1 |
| Barnard, GF | 1 |
| Scharf, MJ | 1 |
| Dagher, RK | 1 |
| Lyde, CB | 1 |
| Cox, SE | 1 |
| Cruz, PD | 1 |
| Leibowitz, MR | 1 |
| Voss, SP | 1 |
| Beissert, S | 1 |
| Metze, D | 1 |
| Luger, TA | 1 |
| Schwarz, T | 1 |
| Fegan, D | 1 |
| Glennon, J | 1 |
| Rhodes, LE | 1 |
| Coleman, MD | 1 |
| Lewis-Jones, MS | 1 |
| Panzarella, K | 1 |
| Camisa, C | 1 |
| Galambrun, C | 1 |
| Cambazard, F | 1 |
| Clavel, C | 1 |
| Versini, P | 1 |
| Stéphan, JL | 1 |
| Mehravaran, M | 1 |
| Morvay, M | 1 |
| Molnár, K | 1 |
| Oláh, J | 1 |
| Korom, I | 1 |
| Husz, S | 1 |
| Dobozy, A | 1 |
| Aytekin, S | 1 |
| Inalöz, HS | 1 |
| Harman, M | 1 |
| Akdeniz, S | 1 |
| Deveci, E | 1 |
| Inalöz, SS | 1 |
| Alsaleh, QA | 1 |
| Nanda, A | 1 |
| Al-Baghli, NM | 1 |
| Dvorak, R | 1 |
| Fuxiang, G | 1 |
| Beutner, EH | 1 |
| Tan, HH | 1 |
| Tay, YK | 1 |
| Yasuda, H | 1 |
| Kobayashi, H | 1 |
| Itoh, K | 1 |
| Yamane, M | 1 |
| Nakamura, J | 1 |
| Metry, DW | 1 |
| Hebert, AA | 1 |
| Jordon, RE | 1 |
| Del Forno, C | 1 |
| Giannetti, A | 1 |
| Orecchia, G | 1 |
| Sneddon, IB | 2 |
| Haensch, R | 1 |
| Haim, S | 1 |
| Friedman-Birnbaum, R | 1 |
| Degos, R | 1 |
| Civatte, J | 1 |
| Belaïch, S | 1 |
| Morel, P | 1 |
| Piamphongsant, T | 1 |
| Lindgren, S | 1 |
| Enerbäck, L | 1 |
| Freiberg, N | 1 |
| Drago, F | 1 |
| Miller, K | 1 |
| Hartmann, AA | 1 |
| Burg, G | 1 |
| Wooldridge, WE | 1 |
| Salomon, D | 1 |
| Saurat, JH | 1 |
| Romanenko, GF | 1 |
| Vyborov, AM | 1 |
| Rodan, KP | 1 |
| Hu, CH | 1 |
| Nickoloff, BJ | 1 |
| Basset, N | 1 |
| Guillot, B | 1 |
| Michel, B | 1 |
| Meynadier, J | 1 |
| Guilhou, JJ | 1 |
| Hombal, S | 1 |
| Sneddon, I | 1 |
| Church, R | 1 |
| Mustakallio, KK | 1 |
| Blomqvist, K | 1 |
| Laiho, K | 1 |
| Emmerson, RW | 1 |
| Wilson-Jones, E | 1 |
| DeMento, FJ | 1 |
| Grover, RW | 1 |
| Fry, L | 1 |
| Seah, PP | 1 |
| Barranco, VP | 1 |
| Johnson, B | 1 |
| Connor, B | 1 |
| Sire, DJ | 1 |
| Johnson, BL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients[NCT04096222] | 42 participants (Anticipated) | Observational | 2021-06-29 | Recruiting | |||
| A Prospective Randomized Placebo-Controlled Clinical Trial of Dapsone as a Glucocorticoid-Sparing Agent in Maintenance Phase Pemphigus Vulgaris[NCT00429533] | Phase 2 | 48 participants | Interventional | 1996-11-30 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
19 reviews available for dapsone and Pemphigus
| Article | Year |
|---|---|
[Dapsone in the treatment of pemphigus foliaceus: A clinical series of 23 cases and a literature review].
Topics: Dapsone; Humans; Pemphigus; Research | 2020 |
Pemphigus and COVID-19: Critical overview of management with a focus on treatment choice.
Topics: COVID-19; Dapsone; Dermatologic Agents; Doxycycline; Glucocorticoids; Humans; Immunoglobulins, Intra | 2020 |
Pediatric Pemphigus Herpetiformis: Case Report and Review of the Literature.
Topics: Anti-Infective Agents; Child, Preschool; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differential; | 2017 |
Pemphigus herpetiformis - a case report of a rare form of pemphigus and review of the literature.
Topics: Adrenal Cortex Hormones; Aged; Autoantibodies; Azathioprine; Biomarkers; Biopsy; Dapsone; Dermatitis | 2016 |
Subcorneal Pustular Dermatosis: A Review of 30 Years of Progress.
Topics: Connective Tissue Diseases; Dapsone; Diagnosis, Differential; Glucocorticoids; Hematologic Diseases; | 2016 |
Pemphigus foliaceus with circinated plaques and neutrophil pustules.
Topics: Dapsone; Female; Humans; Neutrophils; Pemphigus; Prednisolone; Recurrence; Young Adult | 2016 |
Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data.
Topics: Dapsone; Humans; Pemphigoid, Bullous; Pemphigus | 2009 |
Rituximab in childhood pemphigus vulgaris: a long-term follow-up case and review of the literature.
Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Azathioprine; B-Lymphocytes; Chi | 2010 |
Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Dapsone; Dermatologic Agents; Epidermal Growth Factor; | 2011 |
Pemphigus: current therapy.
Topics: Animals; Antirheumatic Agents; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dapsone; | 2004 |
Treatment of pemphigus vulgaris: current and emerging options.
Topics: Administration, Oral; Adrenal Cortex Hormones; Combined Modality Therapy; Dapsone; Dexamethasone; Fe | 2005 |
From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research.
Topics: Abscess; Anti-Inflammatory Agents; Arthritis; Case Management; Dapsone; Digestive System Diseases; F | 2006 |
Adjuvant therapy of pemphigus.
Topics: Adrenal Cortex Hormones; Antibodies; Azathioprine; Cell Count; Clinical Trials as Topic; Cyclophosph | 1984 |
Pemphigus and pemphigoid in dog and man: comparative aspects.
Topics: Animals; Aurothioglucose; Dapsone; Dog Diseases; Dogs; Fluorescent Antibody Technique; Humans; Mouth | 1981 |
Pemphigus erythematosus in a five-year-old child.
Topics: Administration, Oral; Child; Dapsone; Erythema; Female; Humans; Pemphigus; Prednisone | 1994 |
Subcorneal pustular dermatosis type of IgA pemphigus: demonstration of autoantibodies to desmocollin-1 and clinical review.
Topics: Adult; Anti-Infective Agents; Autoantibodies; Dapsone; Desmocollins; DNA, Complementary; Drug Therap | 2000 |
[Herpetiform pemphigus].
Topics: Autoantibodies; Cadherins; Dapsone; Desmoglein 1; Desmoglein 3; Diagnosis, Differential; Humans; Imm | 2000 |
[IgA pemphigus].
Topics: Autoantibodies; Cytoskeletal Proteins; Dapsone; Desmoplakins; Diagnosis, Differential; Humans; Immun | 2000 |
Therapy of pemphigus.
Topics: Antirheumatic Agents; Chronic Disease; Combined Modality Therapy; Cytotoxins; Dapsone; Humans; Organ | 1988 |
2 trials available for dapsone and Pemphigus
| Article | Year |
|---|---|
Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cross-Over | 2008 |
Adjuvant therapy of pemphigus.
Topics: Adrenal Cortex Hormones; Antibodies; Azathioprine; Cell Count; Clinical Trials as Topic; Cyclophosph | 1984 |
92 other studies available for dapsone and Pemphigus
| Article | Year |
|---|---|
Rescue treatment with intravenous immunoglobulin and amniotic membrane dressing in refractory paediatric pemphigus vulgaris with sepsis.
Topics: Azathioprine; Biological Dressings; Child; Dapsone; Humans; Immunoglobulins, Intravenous; Pemphigus; | 2023 |
Anti-desmoglein 1 IgG/IgA pemphigus associated with thymoma.
Topics: Adult; Autoantibodies; Dapsone; Desmoglein 1; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobu | 2017 |
An Unusual Vesiculopustular Eruption: Challenge.
Topics: Aged; Biopsy, Needle; Dapsone; Diagnosis, Differential; Erythema; Female; Humans; Immunoglobulin A; | 2018 |
Psoriasiform Pemphigus Foliaceus in an African American Female: An Important Clinical Manifestation.
Topics: Administration, Oral; Black or African American; Dapsone; Diagnosis, Differential; Female; Humans; L | 2018 |
Pemphigus herpetiformis in South Tunisia: a clinical expression of pemphigus foliaceus?
Topics: Adrenal Cortex Hormones; Adult; Anti-Infective Agents; Complement C3; Dapsone; Desmoglein 1; Erythem | 2018 |
An annular pruritic eruption.
Topics: Adult; Biopsy; Dapsone; Dermatitis Herpetiformis; Female; Humans; Pemphigus; Pruritus; Skin | 2019 |
An Unusual Vesiculopustular Eruption: Answer.
Topics: Aged; Biopsy, Needle; Dapsone; Diagnosis, Differential; Erythema; Female; Fluorescent Antibody Techn | 2018 |
IgG/IgA pemphigus: Report of a rare subtype of pemphigus.
Topics: Aged; Dapsone; Female; Humans; Immunoglobulin A; Immunoglobulin G; Pemphigus | 2019 |
Successful treatment of pyostomatitis vegetans with ulcerative colitis using dapsone without systemic steroids.
Topics: Adult; Anti-Infective Agents; Colitis, Ulcerative; Dapsone; Diagnosis, Differential; Female; Humans; | 2019 |
Pemphigus vegetans of the tongue: a diagnostic and therapeutic challenge.
Topics: Aged; Anti-Infective Agents; Dapsone; Female; Glucocorticoids; Humans; Pemphigus; Prednisone; Tongue | 2013 |
Recalcitrant pemphigus herpetiformis with high titer of immunoglobulin G antibody to desmoglein 1 and positive IgG antibody to desmocollin 3, elevating thymus and activation-regulated chemokine.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Chemokine CCL17; Dapsone; Desmocollins; Desmoglein 1; F | 2014 |
[Efficacy of acitretin in IgA pemphigus].
Topics: Acitretin; Aged, 80 and over; Betamethasone; C-Reactive Protein; Dapsone; Female; Humans; Immunoglob | 2013 |
IgA pemphigus: case series with emphasis on therapeutic response.
Topics: Acitretin; Adalimumab; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antib | 2014 |
Case of pemphigus herpetiformis with immunoglobulin G autoantibodies against desmocollin-3.
Topics: Administration, Cutaneous; Administration, Oral; Autoantibodies; Autoantigens; Biopsy; Collagen Type | 2017 |
Pemphigus Herpetiformis With Autoantibodies to Desmoglein 1 and 3.
Topics: Adult; Autoantibodies; Autoantigens; Dapsone; Dermatitis Herpetiformis; Desmoglein 1; Desmoglein 3; | 2016 |
Efficacy of Dapsone in the Treatment of Pemphigus Vulgaris: A Single-Center Case Study.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Dapsone; Drug Therapy, Combination; Fe | 2016 |
Do safe and effective treatment options exist for patients with active pemphigus vulgaris who plan conception and pregnancy?
Topics: Administration, Oral; Adult; Anti-Infective Agents; Dapsone; Dose-Response Relationship, Drug; Drug | 2008 |
A clinical study of patients with pemphigus vulgaris and pemphigus foliaceous: an 11-year retrospective study (1996-2006).
Topics: Adrenal Cortex Hormones; Adult; Anti-Infective Agents; Dapsone; Diagnosis, Differential; Female; Hum | 2008 |
Subcorneal pustular dermatosis in a patient with rheumatoid arthritis and diffuse scleroderma.
Topics: Adult; Arthritis, Rheumatoid; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differential; Female; Hu | 2009 |
Herpetiform pemphigus without anti-desmoglein 1/3 autoantibodies.
Topics: Aged; Autoantibodies; Carcinoma, Squamous Cell; Dapsone; Desmoglein 1; Desmoglein 3; Desmosomes; Eos | 2010 |
Recalcitrant pemphigus vulgaris responding to systemic tacrolimus.
Topics: Adrenal Cortex Hormones; Aged; Autoantibodies; Azathioprine; Cyclophosphamide; Dapsone; Dermatologic | 2010 |
[Pemphigus].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Biopsy; Da | 2010 |
Letter: Pemphigus herpetiformis of age of onset at 6 years.
Topics: Child; Dapsone; Dermatitis Herpetiformis; Dermatologic Agents; Female; Humans; Pemphigus; Prednisone | 2011 |
An unusual clinical presentation of pemphigus herpetiformis with marked response to dapsone.
Topics: Adult; Anti-Infective Agents; Biopsy, Needle; Dapsone; Dermatitis Herpetiformis; Dose-Response Relat | 2011 |
Pemphigus vulgaris in three adolescents: the course of the disease.
Topics: Adolescent; Azathioprine; Dapsone; Dexamethasone; Drug Therapy, Combination; Female; Glucocorticoids | 2011 |
Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived | 2011 |
[IgA pemphigus of the subcorneal pustular dermatosis type. Successful therapy with a combination of dapsone and acitretin].
Topics: Acitretin; Aged; Dapsone; Drug Combinations; Folic Acid Antagonists; Humans; Immunoglobulin A; Kerat | 2012 |
Late onset of multiple myeloma in a patient with immunoglobulin A pemphigus.
Topics: Acantholysis; Aged; Antineoplastic Agents; Colchicine; Dapsone; Dermatologic Agents; Female; Humans; | 2012 |
Pemphigus in elderly adults: clinical presentation, treatment, and prognosis.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Dapsone; Enzy | 2012 |
IgA pemphigus: the first two Scandinavian cases.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Blister; Dapsone; Dermatologic Agents; Diagnosis, | 2002 |
Clinical-pathologic conference: cutaneous paraneoplastic pemphigus associated with benign encapsulated thymoma.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Dapsone; Diagnosis, Differential; Exercise Test; Fe | 2003 |
Desquamative gingivitis: early presenting symptom of mucocutaneous disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Biopsy; Clobetasol; Dapsone; Diagnosis | 2003 |
[Successful treatment of subcorneal pustular type of IgA pemphigus].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Corneal Diseases; Dapsone; Humans; Immunoglobulin A; Male; | 2005 |
Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.
Topics: Adult; Aged; Biopsy, Needle; Dapsone; Dose-Response Relationship, Drug; Drug Administration Schedule | 2005 |
Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amenorrhea; Azathioprine; Betamethasone; Blood Pressure; | 2005 |
A case of drug-induced hypersensitivity syndrome showing transient immunosuppression before viral reactivation during treatment for pemphigus foliaceus.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Cytomegalovirus; Dapsone; Desmoglein 1; Drug Hyp | 2006 |
Epidemiology of pemphigus in south-western Iran: a 10-year retrospective study (1991-2000).
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Anti-Infective Agents; Azathioprine; C | 2006 |
Blistering disease in a child.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Blister; Child, Preschool; Dapsone; Fluorescent Antibody Te | 2006 |
Pemphigus foliaceus induced by radiotherapy and responsive to dapsone.
Topics: Adenocarcinoma; Aged; Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Dapsone; Female; Hu | 2006 |
IgA pemphigus--occurrence of anti-desmocollin 1 and anti-desmoglein 1 antibody reactivity in an individual patient.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Autoantibodies; Autoantigens | 2006 |
Cutaneous pemphigus vulgaris.
Topics: Anti-Inflammatory Agents; Cyclophosphamide; Dapsone; Diagnosis, Differential; Drug Therapy, Combinat | 2007 |
Dapsone-induced infectious mononucleosis-like syndrome in a patient with pemphigus vulgaris.
Topics: Adult; Dapsone; Humans; Infectious Mononucleosis; Male; Pemphigus; Syndrome | 2007 |
Immunoglobulin A pemphigus involving the perianal skin and oral mucosa: an unusual presentation.
Topics: Anti-Infective Agents; Anus Diseases; Autoantigens; Dapsone; Female; Glucocorticoids; Humans; Immuno | 2007 |
IgG/IgA pemphigus with dyskeratotic acantholysis and intraepidermal neutrophilic microabscesses.
Topics: Acantholysis; Autoantibodies; Dapsone; Desmoglein 1; Desmoglein 3; Folic Acid Antagonists; Humans; I | 2007 |
Treatment of pemphigus: the need for more evidence.
Topics: Dapsone; Drug Therapy, Combination; Humans; Needs Assessment; Pemphigus; Prednisone; Prognosis; Rand | 2008 |
Treatment failure with rituximab in a patient with pemphigus vulgaris.
Topics: Aged; Anti-Infective Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathio | 2008 |
Juvenile pemphigus.
Topics: Adolescent; Adrenocorticotropic Hormone; Age Factors; Azathioprine; Child; Child, Preschool; Cortiso | 1983 |
The effect of corticosteroids, dapsone and gold upon plasminogen activator synthesis and secretion by human epidermal cells cultured with pemphigus antibody.
Topics: Antibodies; Cells, Cultured; Dapsone; Epidermis; Gold Sodium Thiomalate; Humans; Hydrocortisone; Inf | 1984 |
[Erythromelanoderma in pemphigus herpetiformis associated with eosinophilic spongiosis].
Topics: Dapsone; Dermatitis, Exfoliative; Eosinophilia; Female; Humans; Melanosis; Middle Aged; Pemphigus; S | 1980 |
Acantholysis produced in vitro with pemphigus serum: hydrocortisone inhibits acantholysis, while dapsone and 6-mercaptopurine do not inhibit acantholysis.
Topics: Acantholysis; Autoantibodies; Dapsone; Humans; Hydrocortisone; Mercaptopurine; Organ Culture Techniq | 1984 |
[Pemphigus herpetiformis: a clinical variant of pemphigus vulgaris].
Topics: Aged; Autoantibodies; Complement C3; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differential; Epi | 1980 |
When and how to use sulfones in bullous diseases.
Topics: Adrenal Cortex Hormones; Child; Chronic Disease; Dapsone; Dermatitis Herpetiformis; Diagnosis, Diffe | 1981 |
Urticaria as presenting manifestation of pemphigus herpetiformis.
Topics: Administration, Topical; Adult; Aminopyrine; Anti-Inflammatory Agents; Dapsone; Female; Humans; Midd | 1982 |
Pemphigus vegetans: its relationship to eosinophilic spongiosis and favorable response to dapsone.
Topics: Dapsone; Edema; Eosinophils; Female; Humans; Male; Middle Aged; Pemphigus; Skin Diseases; Stomatitis | 1980 |
Sulfone syndrome in a patient receiving steroids for pemphigus.
Topics: Aged; Chemical and Drug Induced Liver Injury; Dapsone; Drug Hypersensitivity; Drug Therapy, Combinat | 1994 |
Juvenile pemphigus foliaceous: response to dapsone.
Topics: Child; Dapsone; Female; Humans; Pemphigus | 1993 |
[Pemphigus herpetiformis].
Topics: Adult; Biopsy; Complement C3; Dapsone; Drug Therapy, Combination; Female; Fluorescent Antibody Techn | 1993 |
Use of steroids in dermatological emergencies.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antitubercular Agents; Child; Dapsone; Emergency Medical Serv | 1993 |
Dapsone-induced motor peripheral neuropathy in pemphigus foliaceus.
Topics: Adult; Dapsone; Female; Humans; Leprostatic Agents; Pemphigus; Peripheral Nervous System Diseases | 1995 |
Coexistence of superficial pemphigus and psoriasis.
Topics: Anti-Inflammatory Agents; Antigenic Modulation; Autoimmune Diseases; Dapsone; Erythema; Etretinate; | 1996 |
Pemphigus foliaceus.
Topics: Child; Dapsone; Dermatologic Agents; Humans; Immunoglobulin G; Male; Pemphigus | 1997 |
Juvenile pemphigus foliaceus.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Child; Dapsone; Female; Fluorescent An | 1998 |
Coexistence of psoriasis vulgaris and bullous disorders.
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Dermatitis Herpeti | 1999 |
Pemphigus in Kuwait.
Topics: Age of Onset; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cushi | 1999 |
Pemphigus erythematosus associated with thymoma: a case report.
Topics: Cicatrix; Dapsone; Drug Therapy, Combination; Humans; Male; Middle Aged; Pemphigus; Postoperative Co | 1999 |
An unusual case of pemphigus vulgaris presenting as bilateral foot ulcers.
Topics: Anti-Inflammatory Agents; Dapsone; Drug Therapy, Combination; Follow-Up Studies; Foot Ulcer; Humans; | 2000 |
Nonendemic pemphigus foliaceus in children.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Child, Preschool; Dapsone; Diagno | 2002 |
Chronic bullous dermatosis of childhood.
Topics: Adrenal Cortex Hormones; Child, Preschool; Chronic Disease; Dapsone; Dermatitis Herpetiformis; Fluor | 1979 |
[Subcorneal pustular dermatosis].
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Blister; Dapsone; Dermatitis Herpetiformis; | 1977 |
Subcorneal pustular dermatosis.
Topics: Aged; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differential; Humans; Impetigo; Male; Middle Age | 1977 |
[Pemphigus herpetiformis].
Topics: Aged; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differential; Female; Humans; Pemphigus | 1979 |
Dapsone in the treatment of pemphigus vulgaris.
Topics: Adult; Dapsone; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Pemp | 1978 |
[Pemphigus with clinical aspect of Darier's erythema annular centrifugum and histological picture of eosinophilic spongiosis].
Topics: Aged; Dapsone; Edema; Erythema Multiforme; Female; Humans; Pemphigus; Skin Diseases | 1978 |
Pemphigus controlled by dapsone.
Topics: Adult; Dapsone; Fluorescent Antibody Technique; Humans; Immunoglobulin G; Male; Pemphigus; Skin | 1976 |
Oral acantholytic itching disease responding to dapsone. Dermatitis herpetiformis, pemphigus, or a new disease?
Topics: Acantholysis; Adult; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differential; Humans; Male; Mouth | 1976 |
Pemphigus and intraepidermal IgA.
Topics: Aged; Dapsone; Humans; Immunoglobulin A; Male; Pemphigus; Skin | 1992 |
IgA pemphigus foliaceus: a case report.
Topics: Aged; Aged, 80 and over; Dapsone; Drug Therapy, Combination; Etretinate; Humans; Immunoglobulin A; M | 1990 |
Three blistering diseases. Why proper management is critical.
Topics: Adrenal Cortex Hormones; Adult; Dapsone; Dermatitis Herpetiformis; Diet; Female; Glutens; Humans; Ma | 1990 |
Oral gold therapy (Auranofin) in pemphigus vulgaris.
Topics: Administration, Oral; Adult; Auranofin; Aurothioglucose; Cyclophosphamide; Dapsone; Female; Gold; Hu | 1986 |
[A case of Hailey-Hailey benign chronic familial pemphigus treated with dimocifon].
Topics: Adult; Chronic Disease; Dapsone; Drug Combinations; Humans; Male; Pemphigus; Uracil | 1988 |
Malodorous intertriginous pustules and plaques. Pemphigus vegetans, Hallopeau type.
Topics: Aged; Complement C3; Dapsone; Female; Fluorescent Antibody Technique; Humans; Immunoglobulin G; Odor | 1987 |
Dapsone as initial treatment in superficial pemphigus. Report of nine cases.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Cyclophosphamide; Dapsone; Drug Resistance; Extracel | 1987 |
Use of cyclophosphamide in azathioprine failures in pemphigus.
Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Dapsone; Drug Therapy, Combination; Female; Humans; Mal | 1987 |
Pemphigus foliaceus presenting as dermatitis herpetiformis.
Topics: Adrenocorticotropic Hormone; Aged; Biopsy; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differentia | 1967 |
Papillary deposition of fibrin, a characteristic of initial lesions of dermatitis herpetiformis.
Topics: Blister; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differential; Erythema Multiforme; Fibrin; Fl | 1970 |
Eosinophilic spongiosis in pemphigus. A report of an unusual hitological change in pemphigus.
Topics: Adrenocorticotropic Hormone; Aged; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differential; Eczem | 1968 |
Acantholytic herpetiform dermatitis.
Topics: Acantholysis; Antibodies; Antibodies, Antinuclear; Biopsy; Blister; Dapsone; Dermatitis Herpetiformi | 1973 |
Dermatitis herpetiformis: an evaluation of diagnostic criteria.
Topics: Adult; Aged; Biopsy; Dapsone; Dermatitis Herpetiformis; Erythrocytes; Female; Fluorescent Antibody T | 1974 |
Mixed bullous disease.
Topics: Adolescent; Aged; Antibodies; Blister; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differential; F | 1974 |
Benign familial chronic pemphigus treated with dapsone.
Topics: Adult; Chronic Disease; Dapsone; Female; Humans; Male; Middle Aged; Pemphigus | 1972 |
Herpetiform pemphigus foliaceus responsive to dapsone.
Topics: Dapsone; Dermatitis Herpetiformis; Humans; Middle Aged; Pemphigus; Ultraviolet Rays | 1972 |
Benign familial chronic pemphigus treated with dapsone.
Topics: Adult; Chronic Disease; Dapsone; Female; Humans; Male; Middle Aged; Pemphigus | 1971 |